Palisade Bio (PALI) Cash from Operations (2010 - 2026)
Palisade Bio (PALI) reported Cash from Operations of 3890000.0 for Q1 2026, down 66.74% year-over-year from 11695064.43 in Q1 2025, and down 23.73% quarter-over-quarter from 3144000.0 in Q4 2025.
Palisade Bio (PALI) Cash from Operations (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Cash from Operations data on file, last reported at 3890000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 3890000.0, down 66.74% year-over-year; the trailing twelve-month figure through Mar 2026 was 12404000.0 (down 9.32% YoY), and the FY2025 annual result was 10847000.0, up 11.04% from the prior year.
- Cash from Operations retreated to 3890000.0 in Q1 2026 per PALI's latest filing, from 3144000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 1817000.0 in Q2 2025 and troughed at 3890000.0 in Q1 2026.
- A 5-year average of 3024882.35 and a median of 3144000.0 in 2025 frame the typical range for Cash from Operations.
- On a YoY basis, Cash from Operations climbed as much as 57.91% in 2022 and fell as far as 201.12% in 2022.
- A 5-year view of Cash from Operations shows it stood at 3306000.0 in 2022, then climbed by 16.94% to 2746000.0 in 2023, then grew by 13.29% to 2381000.0 in 2024, then slumped by 32.05% to 3144000.0 in 2025, then slipped by 23.73% to 3890000.0 in 2026.
- Business Quant data shows PALI's Cash from Operations at 3890000.0 in Q1 2026, 3144000.0 in Q4 2025, and 3553000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | -3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.89 Mn |
| Mar 31, 2026 | -3.89 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Jun 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -1.82 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Sep 30, 2024 | -3.13 Mn |
| Sep 30, 2024 | -3.13 Mn |
| Jun 30, 2024 | -3.50 Mn |
| Jun 30, 2024 | -3.50 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Dec 31, 2023 | -2.75 Mn |
| Dec 31, 2023 | -2.75 Mn |